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Abstract
The E3-ubiquitin ligase, c-Cbl, is a multi-functional scaffolding protein that plays a pivotal role in controlling cell phenotype.
As part of the ubiquitination and downregulation process, c-Cbl recognizes targets, such as tyrosine kinases and the Sprouty
proteins, by binding to a conserved (NX/R)pY(S/T)XXP motif via its uniquely embedded SH2 domain (TKB domain). We
previously outlined the mode of binding between the TKB domain and various substrate peptide motifs, including
epidermal growth factor receptor (EGFR) and Sprouty2 (Spry2), and demonstrated that an intrapetidyl hydrogen bond forms
between the (pY-1) arginine or (pY-2) asparagine and the phosphorylated tyrosine, which is crucial for binding. Recent
reports demonstrated that, under certain types of stimulation, the serine/threonine residues at the pY+1 and/or pY+2
positions within this recognition motif of EGFR and Sprouty2 may be endogenously phosphorylated. Using structural and
binding studies, we sought to determine whether this additional phosphorylation could affect the binding of the TKB
domain to these peptides and consequently, whether the type of stimulation can dictate the degree to which substrates
bind to c-Cbl. Here, we show that additional phosphorylation significantly reduces the binding affinity between the TKB
domain and its target proteins, EGFR and Sprouty2, as compared to peptides bearing a single tyrosine phosphorylation. The
crystal structure indicates that this is accomplished with minimal changes to the essential intrapeptidyl bond and that the
reduced strength of the interaction is due to the charge repulsion between c-Cbl and the additional phosphate group. This
obvious reduction in binding affinity, however, indicates that Cbl’s interactions with its TKB-centered binding partners may
be more favorable in the absence of Ser/Thr phosphorylation, which is stimulation and context specific in vivo. These results
demonstrate the importance of understanding the environment in which certain residues are phosphorylated, and the
necessity of including this in structural investigations.
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Introduction
The epidermal growth factor receptor (EGFR) is a 170 kDa
transmembrane glycoprotein and, similar to a number of other
tyrosine kinases, it has an important role in the regulation of a wide
range of cellular functions. EGFR is activated by specific ligands,
including EGF and transforming growth factor a (TGF- a), which
stimulates receptor dimerization and the onset of intrinsic tyrosine
kinaseactivity[1,2,3].Thisinturnresultsintheautophosphorylation
of multiple residues within the intracellular region [4], a mechanism
commontovarioustyrosinekinases,leadingtodownstreamsignaling
and changes to cell phenotype. Activating mutations, receptor
overexpression and other modes of signal amplification from EGFR
can prohibit the proper attenuation of the signal, and have been
linked to causing a range of cancers, particularly lung cancer [5,6,7].
As as result, EGFR regulation has become the focus of many
research laboratories. Given that the kinase can undergo rapid
autophosphorylation, it is imperative that a mechanism is in place to
strictly control receptor signaling; one key mechanism is through c-
Cbl-mediated ubiquitination and degradation.
The protein product of the Casitas B-lineage lymphoma (c-Cbl)
gene is a multi-domain, multi-functional scaffolding protein with
E3-ubiquitin ligase activity that is crucial for regulating cell
signaling pathways. c-Cbl regulates cell proliferation, differentia-
tion and morphology in response to growth factors, hormones and
cytokines [8,9], binding to substrates via its tyrosine-kinase binding
motif (TKB) in its N-terminus. Through a cascade of steps, c-Cbl
then induces the ligation of ubiquitin molecules to its substrates,
targeting them for internalization and degradation. Elucidating
the TKB recognition sequence has been central to understanding
the biochemistry of tyrosine kinase downregulation by Cbl
proteins. Until recently, the c-Cbl TKB domain was thought to
have an uncharacteristically flexible binding mode, utilizing three
disparate motifs – (D/N)XpY(S/T)XXP or RpY(S/T)XXP or
DpYR – to accomplish its task [10,11,12,13]. The TKB domain is
essentially an embedded SH2 domain, and experimental prece-
dent had indicated that SH2 domains employ a relatively rigid
recognition strategy for binding target proteins, which contrasted
with the supporting Cbl literature. This led us to investigate how
Cbl achieved such flexibility in binding, and whether there was a
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reported the crystal structures of the c-Cbl TKB domain in
complex with peptides derived from Sprouty2, Sprouty4, EGFR,
Syk tyrosine kinase and c-Met receptor [14], and found that the c-
Cbl TKB domain indeed employed a unique mechanism for
binding that was almost identical across the different substrates.
The c-Met motif, DpYR, interacted with Cbl in the reverse
orientation, and an obligatory intrapeptidyl bond formed between
the phosphorylated tyrosine and the (pY-1)Arg (EGFR and
reversed c-Met) or the (pY-2)Asn (Sprouty2, Sprouty4 and Syk).
This bond was essential for orientating the peptide into the
positively-charged binding pocket on Cbl, to permit binding. In
the absence of the residue in the pY-1 or -2 positions, respectively,
binding was abolished.
In examining Cbl’s interaction with target proteins, we and
others did not examine the degree to which phosphorylation of an
adjacent Ser or Thr residue at the pY+1 position in the consensus
sequence would impact on the binding affinity of c-Cbl with its
targets. While there is an abundance of evidence both in vitro and
in vivo to show that phosphorylation of Tyr1069 on EGFR is
crucial for c-Cbl binding and receptor ubiquitination, it is less-well
characterized how phosphorylation of the additional serine
residues within the target sequence affects substrate recognition
by c-Cbl. Recent work has revealed that both Ser1070 and
Ser1071, immediately adjacent to the Tyr1069 are critical for
EGFR desensitization, internalization and degradation [15].
Furthermore, these two serine residues can be phosphorylated
by a number of ligands [16], including EGF [17], light-activated
Calphostin-C [18], hydrogen peroxide [19], TAK1 kinase [20],
p38 mitogen-activated protein kinase (MAPK) [21] and UV
irradiation [22], and their phosphorylation leads to receptor
desensitization [17], internalization [18] and is necessary to inhibit
its own kinase activity [23]. Recently, it was reported that
Sprouty2 is also endogenously phosphorylated on the threonine
residue (Thr56) adjacent to the phosphorylated tyrosine in the
pY+1 position in growing culture cells [24]. Similar to EGFR,
Sprouty2 binds to the c-Cbl TKB domain with high affinity via its
phosphorylated c-Cbl binding motif centred on Tyr55. Indeed, we
and others have shown that it binds to and sequesters c-Cbl from
EGFR through this same tyrosine residue, thereby enhancing
EGFR expression levels on the cell surface [25,26,27,28]. In our
previous study, we demonstrated this sequestration model to be
feasible, with Sprouty2 showing a higher binding affinity to c-Cbl
than EGFR [14].
As phosphorylation can cause large structural changes to
binding, we sought to investigate the effect of multiple phosphor-
ylation on the binding between c-Cbl and EGFR or Sprouty2, in
continuation with our earlier work [14]. Furthermore, we wanted
to verify whether this additional phosphorylation would change
the binding affinity of c-Cbl with Sprouty2 and EGFR. Any
variation in binding or the total abrogation of binding, as a result
of this adjacent Ser/Thr phosphorylation, may indicate that a
stimulation-specific interaction exists between c-Cbl and its
particular substrate.
We employed doubly and triply phosphorylated peptides –
pYpT-Spry2, pYpS-EGFR and pYpSpS-EGFR (hereafter simpli-
fied to ppSpry2, ppEGFR and tpEGFR) – and investigated
changes in binding affinity with the TKB domain of c-Cbl. We
also determined the crystal structure of the doubly phosphorylated
EGFR and Spry2 peptides complexed with c-Cbl TKB at 2.2 and
2.1 A ˚ resolutions, respectively, and observed that the phosphate
group of the Ser/Thr residue shifts away from the c-Cbl
phosphotyrosine binding pocket with minor conformational
changes of the peptides in the interacting region. Using Surface
Plasmon Resonance (SPR) studies, we observed that multiple
phosphorylations significantly reduce the binding affinity of the
peptides to the c-Cbl TKB, with the triply phosphorylated peptide
having the lowest affinity amongst all the peptides tested. These
results indicate that, while additional phosphorylation sites will
affect the binding affinity of the peptides to c-Cbl, the overall
conformation of the interaction does not change significantly.
These modifications to the binding affinity suggest that in order to
obtain accurate binding affinity data in structural investigations
truly reflective of the in vivo setting, the type and duration of
stimulation and the effect this stimulation has on the proteins of
interest needs to be fully understood.
Methods
Surface plasmon resonance (SPR)
SPR experiments were performed with a Biacore 3000 (Biacore
AB, Uppsala, Sweden). c-Cbl protein (50 ng/ml, 110 ml, in 5 mM
sodium citrate pH 6.5) was immobilized onto a CM5 Chip as per
the manufacturer’s recommendations. The running buffer con-
sisted of 20 mM Na Hepes, pH 7.0 and 150 mM NaCl.
Experiments were performed at 25uC. Different concentrations
of peptides in running buffer were applied to the chip surface at a
flow rate of 20 ml/min (Figure 1). Regeneration using running
buffer at 50 ml/min for 1 min resulted in a stable baseline
corresponding to the starting baseline level. c-Cbl TKB, that was
immobilized on the reference cells, was inactivated by a 1 min
flow of 10 mM H2SO4 through the cells. The resulting c-Cbl TKB
lost its ability to bind to the phosphorylate peptides and was used
as a control to eliminate false positive bindings, as well as to
confirm complete coverage of nonspecific binding sites. All
sensorgrams were processed using automatic correction for non-
specific bulk refractive index effects. The equilibrium constant
(KD) was determined by the 1:1 Langmuir binding fitting model
provided by the Biacore 3000 instrument software.
Complex formation, crystallization and data collection
Cloning, expression and purification of c-Cbl was performed as
described previously [14]. Multiply phosphorylated peptides of
human Sprouty2
49–61 (IRNTNEpYpTEGPT) and EGFR
1063–1075
(DSFLQRpYpSSDPT, DSFLQRpYpSpSDPT) were purchased
from GL Biochem, reconstituted in c-Cbl-TKB storage buffer,
incubated with purified c-Cbl-TKB in two- to five-fold molar
excess, and concentrated to 5 mg/ml using Amicon Ultra
ultrafiltration devices (Millipore, Billerica, MA). ppSpry2:TKB
complex crystallized using PACT screen solution (condition
number 57: 20% PEG 3350 and 0.2 M K/Na tartrate) by mixing
1 ml of reservoir solution with 1.5 ml of protein (hanging drop) at
room temperature. The ppEGFR:TKB complex crystallization
condition was initially identified from PACT screen and further
optimized. The highest quality crystals of ppEGFR:TKB complex
were obtained when 1 ml of reservoir solution containing 20% (w/
v) PEG 3350, 150 mM NaK tartrate, 0.1 M Bis-Tris propane
pH 6.1 was mixed with 1.5 ml of protein (hanging drop) at room
temperature. For both complexes, diffraction quality crystals were
obtained in 3 days. The mother liquor was supplemented with
20% glycerol for cryo-protection. X-ray diffraction data was
collected in-house with a Bruker X-8 PROTEUM system.
Structure solution and refinement
Diffraction data was integrated and scaled using HKL2000
[29]. Both complex structures were solved using molecular
replacement method with the program MolRep [30] using the
previously determined coordinates of the c-Cbl TKB domain as a
ppEGFR/ppSpry2:c-Cbl Complexes
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molecule in the asymmetric unit. The resulting model with the
electron density map was examined in the program COOT [31],
and necessary manual model building was performed. Several
alternating cycles of map fitting and refinement using the program
Refmac5 [32], led to the convergence of R-values 0.179
(Rfree=0.224) for ppSpry2:TKB and 0.188 (Rfree=0.221) for
ppEGFR:TKB.
Results
Additional phosphorylation reduces peptide binding
affinity
Phosphorylation is an important covalent modification that
precisely controls the outcome of many in vivo functions, and there
is evidence to suggest that multiple sites of phosphorylation may be
present within the c-Cbl binding motif of EGFR and Spry2,
depending on the type of stimulation to which the cells are
exposed. The Ser/Thr residue at the pY+1 position is partially
conserved in a sequence alignment of c-Cbl binding peptides and,
while the phosphorylation of the serine residues Ser1070 and
Ser1071 are essential for the regulation of EGFR expression [15],
the importance of phosphorylation of the pY+1 Thr56 on Spry2 is
less-well understood [24]. Furthermore, it is currently unknown
how a change in the phosphorylation of these adjacent Ser/Thr
residues affects the topographical interaction of substrates with c-
Cbl.
Previously, we identified that the Tyr55 phosphorylated Spry2
peptide (hereafter referred to as pSpry2) showed the highest
binding affinity to the c-Cbl TKB domain as compared to the
Figure 1. SPR kinetic analysis of pSpry2(A), ppSpry2(B), pEGFR(C), ppEGFR(D), tpEGFR(E) binding to c-Cbl TKB domain. Six peptide
concentrations ranging from 40 nM to 125 mM are used for each peptide in this study. Each concentration is repeated two times and the raw data is
shown. The y axis shows the response unit (RU) differences (minus the reference) and the x axis shows the time (s). The kinetic values are listed in
Table 1.
doi:10.1371/journal.pone.0012819.g001
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EGFR peptide [14] (hereafter referred to as pEGFR). We
therefore employed Surface Plasmon Resonance (SPR) to assess
the relative binding affinities of the TKB domain with the singly
phosphorylated pEGFR and pSpry2 and the multiply phosphor-
ylated peptides, pTyr55/pThr56 Spry2 (ppSpry2), pTyr1069/
pSer1070 EGFR (ppEGFR) and pTyr1069/pSer1070/pSer1071
EGFR (tpEGFR) (Table 1).
As compared to pSpry2, the double phosphorylation on Spry2
caused a 12-fold reduction in binding affinity (0.31 mMt o
3.83 mM; Fig. 1A and B). Similarly, the additional phosphoryla-
tion on EGFR significantly reduced the binding affinity of EGFR
to Cbl when compared with the singly phosphorylated EGFR
peptide, with 26- and 31-fold decreases for ppEGFR and tpEGFR,
respectively (Fig. 1C–E). Notably, the difference between the
double and triple phosphorylation for EGFR was not considerable,
suggesting that phosphorylation at the pY+1 position is predom-
inantly responsible for the decrease in binding affinity. Interest-
ingly, the kon and koff are significantly different between the doubly
and triply phosphorylated peptides, with tpEGFR showing an
approximately 10 times slower kon and koff.
The phosphotyrosine interaction site in the c–Cbl TKB domain
is basic, and therefore, we expected that the addition of phosphate
group(s) on Ser1070 and Ser1071 would have enhanced the
interaction between EGFR and c-Cbl. The same would be
predicted for Spry29s interaction with c-Cbl. However, we
observed the opposite, with additional phosphorylation signifi-
cantly reducing the binding affinity of Cbl with EGFR and Spry2.
In order to understand the structural basis for the reduced binding
affinities, we crystallized the complexes of the c-Cbl TKB domain
with the doubly phosphorylated peptides of EGFR and Spry2. As
the triply phosphorylated peptide did not significantly reduce the
binding affinity over the doubly phosphorylated peptide, we did
not investigate this interaction further.
Double phosphorylation is unfavorable for binding and
weakens the interaction
The c-Cbl TKB domain consists of three tightly-connected
domains: a divergent SH2 domain that binds to the phosphor-
ylated tyrosine; a four-helix bundle (4H) which packs against the
SH2 domain and completes the phosphotyrosine binding pocket;
and a calcium-binding EF-hand, which wedges between the SH2
and 4H domains [10]. The close contact between these three
domains is maintained by several hydrogen bonds and an
extensive network of hydrophobic interactions. Consistent with
other studies, our previous study demonstrated that the pSpry2
and pEGFR peptides interact with c-Cbl TKB through (1) a
positively-charged pocket into which the phosphorylated tyrosine
inserts and establishes the majority of the hydrogen bonds, and
(2) a hydrophobic cluster, which forms significant interactions
with the conserved C-terminal proline residue of the bound
peptide.
The structures of ppSpry2:TKB and ppEGFR:TKB co-
complexes were determined to 2.2 and 2.1 A ˚ resolution,
respectively (Table 2), with one complex molecule in the
asymmetric unit of both complexes (Fig. 2). The c-Cbl TKB
domains are similar in both complexes (0.77 A ˚ rmsd for 2427
atoms) and, aside from minor side chain differences, conformation
of the TKB domain is similar to those complexes that we and
others previously described using the single phosphopeptide [14].
The phosphate groups of the phosphorylated Thr56 of Spry2
and the phosphorylated Ser1070 of EGFR are clearly visible in the
electron density maps (Fig. 3). Surprisingly, unlike the phosphate
group of the tyrosine residue, which makes six hydrogen bonding
contacts with c-Cbl, the phosphate groups of Thr56 and Ser1070
have no interaction with c-Cbl and are both shifted away from the
surface (Fig. 2). Given this lack of interaction between the second
phosphate group and c-Cbl TKB domain, it would be expected
that the affinity between c-Cbl and ppEGFR or ppSpry2 would be
unaffected. However, the SPR results show an obvious reduction
in binding affinity for the doubly phosphorylated peptides when
compared with the singly phosphorylated peptides. We noted no
significant differences in the number of hydrogen bond contacts
between c-Cbl and EGFR peptides (Table S1). However, the
orientation of second phosphate group away from the surface of
Cbl suggests that this phosphate group is not favorable. When we
analyzed the electrostatic surface potential (Fig. 4), the results
showed that the region on c-Cbl contacting the pY+1 and pY+2
positions of the peptides is negatively charged, which could repel
the high negative charge on the phosphorylated serine or
threonine residues. When the SH2 domains from the singly and
doubly phosphorylated EGFR:TKB structures are superimposed,
it is clear that the backbone atoms of the phosphoSer1070 and
Ser1071 residues from ppEGFR are slightly pushed back from c-
Cbl surface (largest displacement 1 A ˚) as compared to pEGFR
(estimated coordinate error is 0.24 for ppEGFR and 0.44 for
pEGFR by Luzzati plot) (Fig. 5A). This is in contrast to the
backbone Ca of the pTyr, for which there is a negligible shift when
the two complexes are superimposed. These observations clearly
demonstrate electrostatic repulsion is occurring due to the
additional phosphorylation.
Interestingly, the other residues in the middle of the peptide
remained unchanged (Arg1068 and pTyr1069), and only small
changes were observed in the C-terminal residues (Arg1068 –
Thr1074) between the pEGFR:TKB and the ppEGFR:TKB
complexes. However, a significant conformational change was
observed at the N-terminus of ppEGFR, with residues Ser1064 –
Gln1067 also shifting away from c-Cbl TKB surface. The electron
density map is weak at the N-terminal regions of both complexes;
therefore this change is unlikely due to the additional phosphor-
ylation of Ser1070 at the C-terminus.
The peptides in the pSpry2:TKB and ppSpry2:TKB complex
structures adopted similar conformations (Fig. 5B), with compa-
rable overall interactions. This is in agreement with the smaller
reduction in binding affinity for between ppSpry2 and pSpry2
measured by SPR, as compared with the greater difference
detected between pEGFR and both ppEGFR and tpEGFR.
However, we did observe that the interaction of the Thr56 side
chain of ppSrpy2 with Gln316, which was present in the
Table 1. Binding parameters for the c-Cbl:peptide
interactions.
Peptide Sequence kon koff Kd x2
(M
21s
21)( s
21)( mM)
pSpry2 IRNTNEpYTEGPT 3.7610
5 0.139 0.31 4.85
ppSpry2 IRNTNEpYpTEGPT 7.7610
4 0.295 3.83 6.68
pEGFR DSFLQRpYSSDPT 2.8610
5 0.279 1.00 0.68
ppEGFR DSFLQRpYpSSDPT 6.5610
3 0.167 25.8 0.09
tpEGFR DSFLQRpYpSpSDPT 687 0.022 31.5 3.36
x
2 is the statistical error between the experimental and theoretical models. x
2 is
defined as S (Rf-Rx)
2/(n-p), where Rf is the fitted value at a given point, Rx is the
experimental value at the same point, n is the number of data points, and p is
the number of fitted parameters.
doi:10.1371/journal.pone.0012819.t001
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the ppSpry2 complex due to re-orientation of the side chain
following phosphorylation. The electron density map for ppSpry2
shows well-defined N-terminal residues, with a contribution from
Asn51 at the N-terminus of ppSpry2 that was not seen in the singly
phosphorylated complex [14].
The buried surface areas and dissociation energy barriers of
singly and doubly phosphorylated peptides were analyzed by PISA
[33]. For the purposes of comparison, the same number of residues
from c-Cbl (55–351), Spry2 (52–59) and EGFR (1064–1074) were
used for analysis. The buried surface area for c-Cbl with pSpry2,
ppSpry2, pEGFR or ppEGFR were 1041.6A ˚ 2, 1025.0A ˚ 2,
1331.9A ˚ 2 and 1261.3A ˚ 2, respectively (Table 3), which shows
small differences in the buried area for singly and doubly
phosphorylated peptides (1.6% and 5.4% reduction, respectively).
However, the predicted dissociation energy barriers for the doubly
phosphorylated peptide complexes were significantly lower
(Table 3), indicating that these peptides have a lower affinity for
the TKB domain than the singly phosphorylated peptides. It is
worth mentioning here that the SPR results show that the reduced
affinity is caused by the reduced association rate (kon), rather than
a faster dissociation (koff).
Overall, the orientation of second phosphate group, the
electrostatic surface environment on c-Cbl, the backbone shifts
at the Y+1 and Y+2 positions, and the lowered dissociation energy
barriers suggest that the presence of a phosphate group at pY+1
position is unfavorable for binding, and weakens the affinity
between the peptide and c-Cbl without abolishing the binding
between the two proteins.
Discussion
The aim of this paper was to address the important question of
whether TKB-directed binding to c-Cbl would be disrupted by the
additional serine/threonine phosphorylation that has been
reported to occur endogenously for EGFR and Sprouty2 under
various stimulated conditions. Studies have shown that EGFR can
become phosphorylated on Ser1070 and Ser1071 by a range of
stimuli, and recent work has demonstrated the potential for Thr56
of Spry2 to become phosphorylated in cultured cells. In both cases,
these residues fall within the c-Cbl TKB binding motif, for which
the consensus currently contains only a single phosphorylation on
the tyrosine residue (Tyr1069 and Tyr55, respectively). As a first
step toward understanding what may occur in vivo, we wanted to
Table 2. Crystallographic data and refinement statistics.
Data set ppSpry2-Cbl ppEGFR-Cbl
Data collection*
Cell parameters (A ˚) 122.09, 122.09, 55.69 122.77, 122.77, 55.43
Space group P6 P6
Resolution range (A ˚) 50–2.2 (2.28–2.20) 50–2.06 (2.13–2.06)
Wavelength (A ˚) 1.5418 1.5418
Observed reflections 217204 377642
Unique reflections 24185 29542
Completeness (%) 99.8 (99.5) 99.7 (98.6)
Overall I/sI 16.9 (3.47) 16.6(2.64)
Rsym
a (%) 0.089 (0.436) 0.115(0.399)
Solvent content (%) 61% 60%
Refinement statistics
Resolution range (A ˚) 50–2.2 20–2.1
Rwork
b (no. of reflections) 0.179 (21715) 0.188 (25131)
Rfree
c (no. of reflections) 0.224 (1235) 0.221 (1425)
RMSD bond lengths (A ˚) 0.026 0.024
RMSD bond angles (deg) 2.118 1.760
No. of protein atoms/ligand atoms/water molecules 2435/91/162 2435/100/314
B-factors (A ˚ 2)
Average B-factors of protein atoms 25.38 31.42
rms B-factor of protein atoms 2.02 1.85
Average B-factor of ligand atoms 31.48 39.70
rms B-factor of ligand atoms 3.06 1.89
Ramachandran plot
Most favored regions (%) 97.3 98.0
Generously allowed regions (%) 2.0 2.0
Disallowed regions (%) 0.7 0.0
aRsym = S|Ii -,I.|/S|Ii| where Ii is the intensity of the i
th measurement, and ,I. is the mean intensity for that reflection.
bRwork = S|F obs -F calc|/S|Fobs| where Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.
cRfree = as for Rwork, but for 5.0% of the total reflections chosen at random and omitted from refinement for all datasets.
*The highest resolution bin statistics were given in the parenthesis.
doi:10.1371/journal.pone.0012819.t002
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threonine residue(s) would significantly alter peptide binding to
the c-Cbl TKB domain. Further, we sought to determine whether
this additional phosphorylation could significantly alter the
binding affinity of proteins to c-Cbl. Our results suggest that
while the binding topography does not significantly change with
the additional phosphorylation, the binding affinity is considerably
reduced by 12- and 30-fold for ppSpry2 and ppEGFR,
respectively. This reduction appears to be primarily due to
phosphorylation at pY+1 position, which is pushed away from the
c-Cbl TKB surface by the phosphate group (Fig. 4). The side chain
of the phosphorylated serine/threonine in ppSpry2 and ppEGFR
is exposed towards the solvent, and thus it might not be involved in
any structural changes.
Figure 2. Crystal structure of TKB:ppSpry2 and TKB:ppEGFR complexes. (A) Ribbon diagram of the TKB:ppSpry2 and (B) TKB:ppEGFR, N-
and C- termini are labeled. c-Cbl-TKB is in gold. ppSpry2 (green) and ppEGFR (magenta) peptides are shown in stick represenations. These figures and
the following figures in this manuscript were prepared using the program PyMol [40].
doi:10.1371/journal.pone.0012819.g002
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PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12819Figure 3. Stereo-view of the 2Fo-Fc simulated annealing omit map of peptides from (A) ppSpry2-Cbl and (B) ppEGFR-Cbl. All atoms
within 3.5 A ˚ of the peptides were omitted prior to refinement. Maps were contoured at a level of 1.0s.
doi:10.1371/journal.pone.0012819.g003
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1046 and 1047 in EGFR (equivalent to Ser1070/1071 in the
current numbering) via the use of multiple point mutations. They
observed that by substituting these serine residues with alanine,
EGF was unable to induce internalization and ubiquitination of
the EGFR, even though the Y1045 (Y1069) was still able to be
phosphorylated by EGF, and the c-Cbl-EGFR interaction was
maintained [15]. These findings show that the serine residues are
not necessary for the c-Cbl-EGFR interaction, which supports our
earlier work revealing that only the (pY-2)Asp or (pY-1)Arg and
the essential pTyr within the TKB binding motif are required to
initiate substrate binding to c-Cbl [14]. The work by Oksvold and
colleagues, however, also suggests that these two adjacent serines
are responsible for directing EGFR internalization and ubiquitina-
tion. This disrupted internalization of serine-mutated EGFR has
also been described elsewhere [34]. Both of these studies utilized
amino acid substitution methods to test the importance of the
serine residues; the substitution of these serine residues for alanine
is not the same as dephosphorylating them and, as the serine side
chain is sterically larger than an alanine side chain, it is plausible
that some structural changes may have also contributed to the
inhibited EGFR internalization. This aside, since binding to Cbl
itself is unchanged, it may be assumed that these serine residues,
whether phosphorylated or not, may be required to bind to
functional complexes of the endocytotic and degradation machin-
ery involved with receptor internalization, including the Cbl
interacting protein of 85 kDa (CIN85) and endophilins, which
bind to the tail end of the receptor during endocytosis [35].
One of c-Cbl’s primary functions in the cell is to target and
suppress the activity of phosphorylated tyrosines on proteins,
particularly tyrosine kinases, through the process of ubiquitination.
However, this process does not directly correlate to c-Cbl binding.
c-Cbl identifies candidate ubiquitination substrates by way of its
TKB domain, and then directs the transfer of ubiquitin molecules
from ubiquitin conjugating (E2) enzymes to these targeted
substrates by virtue of its RING domain, lying adjacent to the
TKB domain (reviewed in [36]). In this regard, the function of the
TKB domain is simple: to identify phosphorylated tyrosine
residues on activated substrates harboring the TKB recognition
sequence. However, the process of ubiquitination is complex, and
not all of c-Cbl’s targets are in fact also ubiquitination targets. For
example, the APS (adapter with a plekstrin homology and Src
homology-2 domains) protein, which binds to the TKB domain
through a derivate of the (NX/R)pY(S/T)XXP sequence – RA(V/
I)XNQpY(S/T) – is not a ubiquitination substrate. Instead, the
APS protein employs c-Cbl as a docker protein in the insulin
receptor complex [37]. While the TKB-binding sequence on APS
harbors some additional residues N-terminal to the phosphotyr-
osine, it still retains the essential Asn residue in the pY-2 position,
and forms the unique intrapeptidyl bond between this residue and
the phosphorylated tyrosine [14]. Therefore, the manner in which
APS binds to c-Cbl is identical to Cbl’s other substrate targets,
suggesting that binding per se has no direct consequence on the
ubiquitination process.
Whilst EGFR and Sprouty2 still bind to c-Cbl TKB domain in
the presence of additional serine phosphorylation, these binding
affinities are weaker than we originally detected with the single
tyrosine phosphorylated peptides [14], and may indicate a weak
association with c-Cbl in cells. However, is not possible to
accurately speculate what might be the physiological outcomes of
Figure 4. The electrostatic surface potential at the region where the phosphorylated peptide binds to the c-Cbl TKB domain.
ppSpry2 peptide is shown in stick representation. The yellow arrows show the negatively-charged region on c-Cbl that electrostatically repels the
phosphate group of the phosphorylated serine (pSer) residue.
doi:10.1371/journal.pone.0012819.g004
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PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e12819Figure 5. Superposition of TKB:peptide complexes. Peptides are shown in colored stick representation, and c-Cbl-TKB is shown in ribbon
representation (gold). (A) ppEGFR (purple) versus pEGFR (yellow). The rmsd between the superimposed TKB SH2 domains from both complexes is
0.351 A ˚ for 81 Ca atoms. The enlarged view shows the peptide shift. The shift of the backbone atoms of the phosphorylated residues at the Y+1, Y+2
and Y+3 positions is approximately 0.7 to 1 A ˚, while the shift of the phosphorylated tyrosine backbone atom is about 0.1 A ˚.( B) ppSpry2 (green)
versus pSpry2 (orange). The SH2 domain (81 Ca atoms) of the TKB from both complexes was superimposed with an rmsd of 0.219 A ˚.
doi:10.1371/journal.pone.0012819.g005
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PLoS ONE | www.plosone.org 9 September 2010 | Volume 5 | Issue 9 | e12819these adjacent phosphorylated residues. A lesser affinity for the c-
Cbl TKB domain is not necessarily directly correlated with less
ubiquitination. Whilst there is a paucity of information on binding
affinity versus ubiquitination, our unpublished observation is that
binding affinity does not correlate with ubiquitination, and this is
partly validated by the high affinity binding in some cases where
ubiquitination is not the final outcome. For instance, we have
measured that the APS protein binds the c-Cbl TKB domain with
high affinity, however it is not ubiquitinated [14]. Similarly,
pSprouty2, which has the highest binding affinity over all the
singly phosphorylated peptides tested, is seemingly poorly
degraded, with cell lysates displaying high expression levels of
Sprouty2 even in the presence of overexpressed c-Cbl in
stimulated conditions [14,38]. The inverse is true for the c-Met
receptor, which shows very weak interactions with c-Cbl in ITC
experiments and in immunoprecipitations, but is very quickly
degraded when c-Cbl is present in abundance [12,14]. This
discrepancy in binding affinity versus ubiquitination has been
reviewed elsewhere [39]. What is likely to be more relevant for
determining the degree of ubiquitination, is the binding affinity of
the conjugated ubiquitin with the target substrate, the mode of
ubiquitination (for example, mono- versus polyubiquitination), and
the E2 or ubiquitin-conjugating enzyme that is employed. Whilst
ubiquitination is unlikely to be directly associated with binding
affinity, the combination of tyrosine and serine phosphorylation
may together provide the optimum chance of ubiquitination
through the complex recruitment of key machinery of the
endocytic pathway.
Protein Data Bank code
Coordinates were deposited with accession codes 3OB1 and
3OB2 for ppSpry2 and ppEGFR respectively.
Supporting Information
Table S1 Hydrogen bond contacts between Spry2 and EGFR
peptides and c-Cbl. These data are generated by ccp4 CON-
TACT program.
Found at: doi:10.1371/journal.pone.0012819.s001 (0.00 MB
PDF)
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